Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

This study has been completed.
Information provided by:
Baqiyatallah Medical Sciences University Identifier:
First received: August 7, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure

Condition Intervention Phase
Drug: furosemide
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Resource links provided by NLM:

Further study details as provided by Baqiyatallah Medical Sciences University:

Primary Outcome Measures:
  • effect of furosemid inhalation on dyspnea


Ages Eligible for Study:   32 Years to 83 Years   (Adult, Senior)
Genders Eligible for Study:   Male

Inclusion Criteria:

  • Patients with a history of exposure to sulfur mustard with a complaint of dyspnea

Exclusion Criteria:

  • A contraindication for furosemide use;
  • An accompanying disease in which other drugs effective for dyspnea were used
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00512811

Iran, Islamic Republic of
Tehran, Iran, Islamic Republic of
Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Study Chair: Mostafa Ghanei, MD Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
  More Information Identifier: NCT00512811     History of Changes
Other Study ID Numbers: 121a25 
Study First Received: August 7, 2007
Last Updated: August 7, 2007
Health Authority: Iran: Ethics Committee

Keywords provided by Baqiyatallah Medical Sciences University:
mustard gas
sulfur mustard

Additional relevant MeSH terms:
Respiratory Aspiration
Respiration Disorders
Respiratory Tract Diseases
Pathologic Processes
Signs and Symptoms, Respiratory
Signs and Symptoms
Bronchial Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Infections
Mustard Gas
Natriuretic Agents
Physiological Effects of Drugs
Sodium Potassium Chloride Symporter Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dermatologic Agents
Alkylating Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents processed this record on January 14, 2017